Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events

Fig. 2

Forest plot of the primary 4-component MACE endpoint by stratum. A comparison of the primary analysis results (HR [98.02 % CI]) in each stratum (study or combinations of studies by which the primary analysis was stratified) with the overall result. Numbers of CV events per each treatment group (Dula/Comparators) are indicated in the parentheses in the y-axis under Stratum

Back to article page